purchase customization

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Molecular Targeted Therapy
1.2 Key Market Segments
1.2.1 Molecular Targeted Therapy Segment by Type
1.2.2 Molecular Targeted Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Molecular Targeted Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Molecular Targeted Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Molecular Targeted Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Molecular Targeted Therapy Market Competitive Landscape
3.1 Global Molecular Targeted Therapy Sales by Manufacturers (2019-2024)
3.2 Global Molecular Targeted Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Molecular Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Molecular Targeted Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Molecular Targeted Therapy Sales Sites, Area Served, Product Type
3.6 Molecular Targeted Therapy Market Competitive Situation and Trends
3.6.1 Molecular Targeted Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Molecular Targeted Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Molecular Targeted Therapy Industry Chain Analysis
4.1 Molecular Targeted Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Molecular Targeted Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Molecular Targeted Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Targeted Therapy Sales Market Share by Type (2019-2024)
6.3 Global Molecular Targeted Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Molecular Targeted Therapy Price by Type (2019-2024)
7 Molecular Targeted Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Targeted Therapy Market Sales by Application (2019-2024)
7.3 Global Molecular Targeted Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Molecular Targeted Therapy Sales Growth Rate by Application (2019-2024)
8 Molecular Targeted Therapy Market Segmentation by Region
8.1 Global Molecular Targeted Therapy Sales by Region
8.1.1 Global Molecular Targeted Therapy Sales by Region
8.1.2 Global Molecular Targeted Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Molecular Targeted Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Molecular Targeted Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Molecular Targeted Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Molecular Targeted Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Molecular Targeted Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Phoenix Molecular Designs
9.1.1 Phoenix Molecular Designs Molecular Targeted Therapy Basic Information
9.1.2 Phoenix Molecular Designs Molecular Targeted Therapy Product Overview
9.1.3 Phoenix Molecular Designs Molecular Targeted Therapy Product Market Performance
9.1.4 Phoenix Molecular Designs Business Overview
9.1.5 Phoenix Molecular Designs Molecular Targeted Therapy SWOT Analysis
9.1.6 Phoenix Molecular Designs Recent Developments
9.2 Prelude Therapeutics
9.2.1 Prelude Therapeutics Molecular Targeted Therapy Basic Information
9.2.2 Prelude Therapeutics Molecular Targeted Therapy Product Overview
9.2.3 Prelude Therapeutics Molecular Targeted Therapy Product Market Performance
9.2.4 Prelude Therapeutics Business Overview
9.2.5 Prelude Therapeutics Molecular Targeted Therapy SWOT Analysis
9.2.6 Prelude Therapeutics Recent Developments
9.3 Tempus
9.3.1 Tempus Molecular Targeted Therapy Basic Information
9.3.2 Tempus Molecular Targeted Therapy Product Overview
9.3.3 Tempus Molecular Targeted Therapy Product Market Performance
9.3.4 Tempus Molecular Targeted Therapy SWOT Analysis
9.3.5 Tempus Business Overview
9.3.6 Tempus Recent Developments
9.4 Bracco
9.4.1 Bracco Molecular Targeted Therapy Basic Information
9.4.2 Bracco Molecular Targeted Therapy Product Overview
9.4.3 Bracco Molecular Targeted Therapy Product Market Performance
9.4.4 Bracco Business Overview
9.4.5 Bracco Recent Developments
9.5 iOmx Therapeutics
9.5.1 iOmx Therapeutics Molecular Targeted Therapy Basic Information
9.5.2 iOmx Therapeutics Molecular Targeted Therapy Product Overview
9.5.3 iOmx Therapeutics Molecular Targeted Therapy Product Market Performance
9.5.4 iOmx Therapeutics Business Overview
9.5.5 iOmx Therapeutics Recent Developments
9.6 OncoDNA
9.6.1 OncoDNA Molecular Targeted Therapy Basic Information
9.6.2 OncoDNA Molecular Targeted Therapy Product Overview
9.6.3 OncoDNA Molecular Targeted Therapy Product Market Performance
9.6.4 OncoDNA Business Overview
9.6.5 OncoDNA Recent Developments
9.7 Sapience Therapeutics
9.7.1 Sapience Therapeutics Molecular Targeted Therapy Basic Information
9.7.2 Sapience Therapeutics Molecular Targeted Therapy Product Overview
9.7.3 Sapience Therapeutics Molecular Targeted Therapy Product Market Performance
9.7.4 Sapience Therapeutics Business Overview
9.7.5 Sapience Therapeutics Recent Developments
9.8 Caris Life Sciences
9.8.1 Caris Life Sciences Molecular Targeted Therapy Basic Information
9.8.2 Caris Life Sciences Molecular Targeted Therapy Product Overview
9.8.3 Caris Life Sciences Molecular Targeted Therapy Product Market Performance
9.8.4 Caris Life Sciences Business Overview
9.8.5 Caris Life Sciences Recent Developments
9.9 Hera Biolabs
9.9.1 Hera Biolabs Molecular Targeted Therapy Basic Information
9.9.2 Hera Biolabs Molecular Targeted Therapy Product Overview
9.9.3 Hera Biolabs Molecular Targeted Therapy Product Market Performance
9.9.4 Hera Biolabs Business Overview
9.9.5 Hera Biolabs Recent Developments
9.10 CV6 Therapeutics
9.10.1 CV6 Therapeutics Molecular Targeted Therapy Basic Information
9.10.2 CV6 Therapeutics Molecular Targeted Therapy Product Overview
9.10.3 CV6 Therapeutics Molecular Targeted Therapy Product Market Performance
9.10.4 CV6 Therapeutics Business Overview
9.10.5 CV6 Therapeutics Recent Developments
9.11 Carrick Therapeutics
9.11.1 Carrick Therapeutics Molecular Targeted Therapy Basic Information
9.11.2 Carrick Therapeutics Molecular Targeted Therapy Product Overview
9.11.3 Carrick Therapeutics Molecular Targeted Therapy Product Market Performance
9.11.4 Carrick Therapeutics Business Overview
9.11.5 Carrick Therapeutics Recent Developments
9.12 Foundation Medicine
9.12.1 Foundation Medicine Molecular Targeted Therapy Basic Information
9.12.2 Foundation Medicine Molecular Targeted Therapy Product Overview
9.12.3 Foundation Medicine Molecular Targeted Therapy Product Market Performance
9.12.4 Foundation Medicine Business Overview
9.12.5 Foundation Medicine Recent Developments
9.13 Cybrexa Therapeutics
9.13.1 Cybrexa Therapeutics Molecular Targeted Therapy Basic Information
9.13.2 Cybrexa Therapeutics Molecular Targeted Therapy Product Overview
9.13.3 Cybrexa Therapeutics Molecular Targeted Therapy Product Market Performance
9.13.4 Cybrexa Therapeutics Business Overview
9.13.5 Cybrexa Therapeutics Recent Developments
10 Molecular Targeted Therapy Market Forecast by Region
10.1 Global Molecular Targeted Therapy Market Size Forecast
10.2 Global Molecular Targeted Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Molecular Targeted Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Molecular Targeted Therapy Market Size Forecast by Region
10.2.4 South America Molecular Targeted Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Molecular Targeted Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Molecular Targeted Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Molecular Targeted Therapy by Type (2025-2030)
11.1.2 Global Molecular Targeted Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Molecular Targeted Therapy by Type (2025-2030)
11.2 Global Molecular Targeted Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Molecular Targeted Therapy Sales (K Units) Forecast by Application
11.2.2 Global Molecular Targeted Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings